See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Natural Disasters
Stock Markets
Social Media
Tariffs
UK Economy
Taxes
Soccer
Donald Trump
Education
Senate
Artificial Intelligence
Published • loading... • Updated

Teleflex Reports Promising Preliminary Results for Ringer PBC Study

Summary by MyChesCo
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has shared promising preliminary results from its Ringer™ PBC IDE study, featured in a presentation at the CTO Plus Conference in New York. The presentation, delivered by the study’s principal investigator, Dr. David E. Kandzari of Piedmont Heart Institute, highlighted the potential of the Ringer™ PBC device in managing coronary perforations during percutaneous coronary intervention (PCI) procedures.…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All
Left
Center
Right
MyChesCoMyChesCo

Teleflex Reports Promising Preliminary Results for Ringer PBC Study

WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has shared promising preliminary results from its Ringer™ PBC IDE study, featured in a presentation at the CTO Plus Conference in New York. The presentation, delivered by the study’s principal investigator, Dr. David E. Kandzari of Piedmont Heart Institute, highlighted the potential of the Ringer™ PBC device in managing coronary perforations during percutaneous coronary intervention (PCI) procedures.…

Read Full Article
Cardiovascular NewsCardiovascular News

Preliminary IDE trial results demonstrate efficacy of dedicated device for coronary perforations - Cardiovascular News

Teleflex has announced that the preliminary results from its Ringer perfusion balloon catheter (PBC) investigational device exemption (IDE) study were reported in a featured presentation at the CTO Plus conference (28 February–1 March, New York, USA) in by the study’s principal investigator, David Kandzari (Piedmont Heart Institute, Atlanta, USA). Ringer PBC is a rapid-exchange percutaneous transluminal coronary angioplasty (PTCA) catheter with …

Read Full Article
stocktitan.netstocktitan.net

Groundbreaking Coronary Device Trial: Ringer PBC Achieves 86% Success Rate in Critical Study

New clinical data reveals Teleflex's perfusion balloon catheter effectively controls coronary perforations with continuous blood flow. FDA submission underway.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news in on Thursday, March 27, 2025.
Sources are mostly out of (0)

Similar News Topics

FDA

FDA

United States

United States

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal